申请人:DAIICHI SANKYO COMPANY, LIMITED
公开号:US11149066B2
公开(公告)日:2021-10-19
Provided is a compound that can promote angiogenesis by inhibiting the function of TSP1, and is useful for the treatment or prophylaxis of diseases such as critical limb ischemia.
Specifically provided is a macrocyclic polypeptide represented by formula (I)
[wherein A is selected from the linking groups A1 to A6; Xaa1 is a residue of an aliphatic amino acid, an aromatic amino acid, a basic amino acid, a neutral amino acid, or an acidic amino acid, or is absent; Xaa2 is a residue of an aromatic amino acid or a neutral amino acid; Xaa3 is a residue of an aliphatic amino acid, an aromatic amino acid, or a basic amino acid; Xaa4 is Ser, Thr, Ala, or mS; Xaa5 is Gly or Ser; Xaa6 is a residue of a basic amino acid or a neutral amino acid; Xaa7 is a residue of a neutral amino acid or an acidic amino acid; Xaa8 is a residue of an aromatic amino acid; Xaa9 is a residue of an aliphatic amino acid, a neutral amino acid, or an aromatic amino acid; Xaa10 is a residue of a basic amino acid, an aliphatic amino acid, an aromatic amino acid, or a neutral amino acid; Xaa11 is a residue of an aromatic amino acid; and Xaa12 is a residue of an aliphatic amino acid, an aromatic amino acid, or a basic amino acid], or a pharmacologically acceptable salt thereof.
本发明提供了一种化合物,该化合物可通过抑制 TSP1 的功能促进血管生成,并可用于治疗或预防危重肢体缺血等疾病。
具体而言,提供了一种由式(I)代表的大环多肽
[其中 A 选自连接基团 A1 至 A6;Xaa1 是脂肪族氨基酸、芳香族氨基酸、碱性氨基酸、中性氨基酸或酸性氨基酸的残基,或者不存在;Xaa2 是芳香族氨基酸或中性氨基酸的残基;Xaa3 是脂肪族氨基酸、芳香族氨基酸或碱性氨基酸的残基; Xaa4 是 Ser、Thr、Ala 或 mS; Xaa5 是 Gly 或 Ser; Xaa6 是碱性氨基酸或中性氨基酸的残基;Xaa7 是中性氨基酸或酸性氨基酸的残基; Xaa8 是芳香族氨基酸的残基; Xaa9 是脂肪族氨基酸、中性氨基酸或芳香族氨基酸的残基;Xaa10 是碱性氨基酸、脂肪族氨基酸、芳香族氨基酸或中性氨基酸的残基; Xaa11 是芳香族氨基酸的残基;以及 Xaa12 是脂肪族氨基酸、芳香族氨基酸或碱性氨基酸的残基],或其药理学上可接受的盐。